Skip to content

The BASIL-3 Trial: Balloon vs. Stenting in Severe Ischaemia of the Leg-3

Multi-centre randomised controlled trial of clinical and cost-effectiveness of drug coated balloons, drug eluting stents and plain balloon angioplasty with bail-out bare metal stent revascularisation strategies for severe limb ischaemia due to atherosclerotic femoro-popliteal, with or without infra-popliteal involvement, peripheral arterial disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14469736
Enrollment
480
Registered
2015-10-22
Start date
2015-11-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe limb ischaemia due to femoro-popliteal disease Circulatory System Peripheral vascular disease, unspecified

Interventions

Participants are randomly allocated to one of three treatment groups. Group 1: Participants receive a plain balloon angioplasty with a bare metal stent (if needed) Group 2: Participants receive a dr

Sponsors

University of Birmingham
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or over 2. Have severe limb ischaemia due to femoro-popliteal, with or without infra-popliteal, peripheral artery disease 3. Be judged by the responsible clinicians (consultant vascular surgeon, interventional radiologist, diabetologist) working as part of a multidisciplinary team to require early endovascular femoro-popliteal, with or without infra-popliteal revascularisation in addition to best medical treatment, foot and wound care 4. Have adequate ‘inflow’ to support all possible trial revascularisation strategies 5. Be judged suitable for all possible trial revascularisation strategies following diagnostic imaging and a formal (documented) discussion by a multi-disciplinary team meeting

Exclusion criteria

Exclusion criteria: 1. Have an anticipated life expectancy <6 months 2. Are unable to provide consent due to incapacity (as defined by Mental Capacity Act 2005 or Adults with Incapacity [Scotland] Act 2000) 3. Are a non-English speaker where translation facilities are insufficient to guarantee informed consent 4. Are judged unsuitable for any of the revascularisation strategies being evaluated

Design outcomes

Primary

MeasureTime frame
Amputation free survival (AFS) defined as the time to major limb (above the ankle) amputation of the index (trial) limb or death from any cause

Secondary

MeasureTime frame
Not provided at time of registration

Countries

England, United Kingdom

Contacts

Public ContactSuzanne Lockyer
BASIL-3@trials.bham.ac.uk+44 (0)121 415 8444

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 10, 2026